Wuhan Ruiqi Bioengineering Co., Ltd. can produce the new crown antigen?

Can, in order to further expand the production capacity of anti-epidemic medicines and devices, the Provincial Bureau of Pharmaceutical Control actively seek the support of the State Drug Administration, and successfully included the registration of antigen detection reagents of Baioda Biotechnology (Wuhan) Co. in the emergency approval. In less than a week, the company got the registration certificate of antigen detection reagent. After that, the Provincial Drug Administration of a number of offices in collaboration, the same day for the company for the production license procedures. For the expansion of production capacity needs of anti-epidemic drugs and equipment manufacturers, the Provincial Drug Administration opened up a special channel to start the emergency review and approval mechanism, has been for the real Ao Honeysuckle Pharmaceutical Co., Ltd. for the commissioned production procedures, for the Wuhan Biological Biological Co.